Recombinant Lactobacillus helveticus PJ4-Down Regulates TLR4 Mediated Inflammatory Responses in Sucrose Induced Diabetic Rats: A Novel Therapeutic Approach

Authors

  • Prasant Kumar Jena Institute of Science, Nirma University, Ahmedabad, Gujarat, India Department of Pathology and Laboratory Medicine, University of California, Davis, CA, USA
  • Bhumika Prajapati Institute of Science, Nirma University, Ahmedabad, Gujarat, India
  • Nidhi Nagar Institute of Science, Nirma University, Ahmedabad, Gujarat, India Department of Pathology and Laboratory Medicine, University of California, Davis, CA, USA
  • Pradyumna Kumar Mishra Translational Research Laboratory, School of Biological Sciences, Dr. Harisingh Gour Central University, Sagar, Madhya Pradesh, India Department of Molecular Biology, National Institute for Research in Environmental Health (ICMR), Bhopal, Madhya Pradesh, India
  • Sweta Patel Institute of Science, Nirma University, Ahmedabad, Gujarat, India
  • Dipeeka Mandaliya Institute of Science, Nirma University, Ahmedabad, Gujarat, India
  • Sriram Seshadri Institute of Science, Nirma University, Ahmedabad, Gujarat, India

DOI:

https://doi.org/10.37591/rrjoi.v7i2.95

Abstract

High sucrose diet (HSD) is known to induce type 2 diabetes. Recombinant Lactobacillus helveticus PJ4 was constructed to express the InuJ gene under the xylose promoter resulting in the secretion of inulosucrase enzyme in gastrointestinal tract which polymerizes the fructose moiety of sucrose to inulin type fructans. L. helveticus (pSLP-InuJ-Vhb) transformant (LHI) was intragastrically administered to rats fed with HSD diet. The composition of fecal microbiota and short-chain fatty acids (SCFA), oral glucose tolerance, blood, liver markers, serum and hepatic lipids profile and proinflammatory cytokines in serum were investigated. Additionally, the histopathological and expression of TLR2, TLR4 and NF-қB genes were also studied in liver, distal ileum and proximal colon. The levels of plasma glucose, liver injury markers, lipid profile in plasma and liver were significantly increased in high-sucrose-fed rats. However, after LHI feeding significantly ameliorated the elevated parameters. Feeding of LHI transformants enhanced the butyrate production compared to HSD group. The mRNA expression analysis revealed that the LHI administration restored the HSD-dysregulated TLR2, TLR4 and NF-кB toward a physiological level in liver, distal ileum, proximal colon and adipose tissue. The LHI significantly reduced the adverse effect of main regulators of inflammatory cytokines, i.e., IL6 and TNF-α in HSD rats. Besides that, it also reduces the other cytokines like MCP-1, INF-γ, and IL12p70. The LHI transformants was effective in reducing the severity of liver injury and insulin resistance, ameliorated hepatic steatosis associated with high sucrose intake, suggesting its possible therapeutic/preventive clinical utilization.

Keywords: Inulosucrase, Lactobacilli, probiotic, Toll like receptors, Cytokines, Insulin resistance

Cite this Article

Prasant Kumar Jena, Bhumika Prajapati, Nidhi Nagar et al. Recombinant Lactobacillus helveticus PJ4-Down Regulates TLR4 Mediated Inflammatory Responses in Sucrose Induced Diabetic Rats: A Novel Therapeutic Approach. Research & Reviews: A Journal of Immunology. 2017; 7(2): 44–65p.

Downloads

Published

2018-01-05

Issue

Vol. 7 No. 2 (2017)

Section

Articles

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.